+ All Categories
Home > Documents > { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD...

{ Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD...

Date post: 18-Jan-2018
Category:
Upload: ashlie-jenkins
View: 222 times
Download: 0 times
Share this document with a friend
Description:
{ as a first choice regime for persons with type 1 diabetes Flexible, Intensive Insulin Therapy FIIT ISPAD recommendation, ADA recommendation, PDA recommendation 10 years ago…
30
{ Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland
Transcript
Page 1: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

{

Practicalities of intesive insulin therapy to optimase diabetes control

Ewa Pańkowska MD, PhD Warsaw, Poland

Page 2: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

At least four injections per day At least four glucose

measurements per day.

Outcomes: Less microvascular complications More severe hypoglycemia events

Intensive Insulin Therapy

DCCT, NEJM, 1993

20 years ago…

Page 3: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

{as a first choice regime for persons

with type 1 diabetes

Flexible, Intensive Insulin TherapyFIIT

ISPAD recommendation,ADA recommendation,PDA recommendation

10 years ago…

Page 4: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

British Medical Journal; 2002;

Conclusion: Skills training promoting dietary freedom improved quality of life and

glycaemic control in people with type 1 diabetes without worsening hypoglycemia

Page 5: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

What FIIT means?

Tsukuda, K. DT&T, 2009

Page 6: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

{

The tools and the algorythmin FIIT

Multiple daily injection vs continuous subcutaneous insulin infusion

Page 7: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

1. There are a lot of evidences that CSII improves metabolic control (HbA1c) comparing to MDI method. Is that True or False?

2. Insulin pump therapy significantly decreases risk of severe hypoglycemia events. True or False?

questions:

Page 8: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

The comparison between MDI and CSII.Are there relevant differences

for metabolic control

Page 9: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

6.00 10.00 12.00 15.00 18.00 20.00 22.00 24.00 3.00 6.00 10.00 12.0060

80

100

120

140

160

180

MDI CSI

Time

glyc

emia

mg/

dl

Pańkowska, E, ADA 2011

00.10.20.30.40.50.60.70.80.9

11.1

P<0,05

P<0,05

Basal insulin IU/kg/d Total daily dose IU/kg/d

MDICSII

Parallel day – to – day study

Page 10: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

Mealtime insulin• Regular insulin• Rapid acting

analogue Basal insulin:

• NPH• Long acting analogue

Delivering insulin:• subcutaneous and

shots administartion

Mealtime insulin• Rapid acting analogue

Basal insulin: • Rapid acting analogue

Delivering insulin:• Subcutaneus and

continuous administartion

* NPH – Isophane insulin (intermediate-acting)

Page 11: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

Number of injection/month average: 120-150

Insulin depot in subcutaneous tissue

basal insulin dose - 20 IU

Logbook as a form of injected insulin dose registration

Number of injection/month average: 8-10

Insulin depot in subcutaneous tissue

Basal: 20 IU/day - 0,8 IU/h

Electronic memory as a form of delivered insulin dose registration

Page 12: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

Basal insulin Once or twice a

day Insulin dose

adaptation once or twice per day

If injected, cannot be revoked

Basal function: Insulin dose adaptation

every hour or every half an hour

Possibility of suspension of basal insulin administration

Possibility of keeping different basal insulin profile in electronic memory – Basal Profiles

Possibility of adaptation of basal insulin for current needs - Temporary basal rate

Page 13: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

Bolus function:• One shot of insulin (RI or

analogue) before the meal

• One meal – one shot of insulin

• One kind of insulin shooting

Correction insulin: combine with meal insulin in one injection

Bolus function: Three kinds of boluses:

Normal (for Carbohydrates) Extended (for Fat-protein) Multiwave (for Mixed)

Possibility of programming one meal bolus as a multi-bolus (before, during and after a meal)

Correction insulin: programmed separately

Page 14: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

The schema of insulin dosing in FIIT

Total daily dose

50% Meal insulin

15% lunch

20% dinner

50% Basal insulin

15% Breakfas

t

?

Page 15: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

Patient’s age Diabetes duration ( years) C-petid residual secretion BMI Concomitant disease and hormonal

therapy

The factors influence basal insulin dose

Page 16: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

Patient’s age and duration of diabetes

1 248 patients with T1DM on insulin pumps

Page 17: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

The Percentage of basal insulin

Age Average SD

Preschooler 34.09 15.93

Prepubertal 43.13 12.48

Pubertal 47.43 12.44

Danne T., Diabetologia, 2008

Age Average SD

Preschooler 20.9 9.2

Prepubertal 26.1 12.50

Pubertal 31.8 12.00

Pańkowska E.. Pediatric Diabetes, 2008

Page 18: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

Duration of diabetes and C-peptide residual secretion

C-peptide and percentage of basal insulin in TDD

Page 19: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

The basal to bolus proportion related to C-peptide

Pańkowska E., Pediatric Diabetes, 2008

* p<0,05

*

Page 20: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

Basal insulin patterns

Page 21: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

Basal insulin dose in children and adolescents

0

0.5

1

1.5

2

01:00 04:00 07:00 10:00 13:00 16:00 19:00 22:00

Insu

lin U

/Hr

preschooler 1-6 ys, 0,2-0,3j/g Prepubertal 7-12 ys , 0,4-0,5j/g

pubertal, 13-18 ys; 0,9-1,0 j/g

0

0.5

1

1.5

2

01:00 04:00 07:00 10:00 13:00 16:00 19:00 22:00

Insu

lin U

/Hr

0

0.5

1

1.5

2

01:00 04:00 07:00 10:00 13:00 16:00 19:00 22:00

Insu

lin U

/Hr

Page 22: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

5years old girl with diabetes from 2 years .Basal insulin 6-10% of TDD

15 years old girl with diabetes from 10 ys

Basal insulin 30-45%of TDD

Page 23: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

Anna , 7 years old Diabetes for second year of life5 years duration, c-peptide naiveAsthma bronchialeHb1c- 6,5% ( average)

Case report

Page 24: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.
Page 25: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

Blood glucose and insulin applaying pl-insmadz.pdf

Page 26: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

Case report

14 years old boy, Diabetes duration 4 years, HbA1c 7,0%

Page 27: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.
Page 28: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

The blood glucose profile and insulin applying Paweł.pdf

Temporal basal rate and sick days

Page 29: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

the proportion of basal to bolus insulin can be ranged from 10% to 60%

Meal daily plan are flexible in term of meal’s size, timing for breakfast, lunch and dinner and meal nutrients contains .

Dual wave boluses/multiwave are applied by patients in their daily care.

Basal rate is lower during a day than night hours,

Summary

Page 30: { Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

Tailoring insulin programming

in pump therapy is one of the

way in getting recommended

metabolic control.

Conclusion


Recommended